IntroductionAn embryonic paratesticular rhabdomyosarcoma is a very rare mesenchymal tumor. It is an intrascrotal tumor that is localized in paratesticular structures such as the epididymis or spermatic cord. Rhabdomyosarcoma is most often observed in children and adolescents, presenting as a painless scrotal mass.Case presentationOur patient was an 18-year-old Moroccan man who presented with a painless left scrotal mass that had evolved over four months. An inguinal orchiectomy was performed. A histological examination of the excised tissue revealed an embryonic rhabdomyosarcoma.Our patient had three sessions of chemotherapy with vincristine, actinomycin C and cyclophosphamide. Each chemotherapy session was conducted over five days, with a cycle of 21 days. Our patient was assessed two months after the last chemotherapy session and demonstrated good clinical improvement.ConclusionParatesticular rhabdomyosarcoma is a rare aggressive tumor manifesting in children and very young adults. Localized forms have a good prognosis whereas metastatic tumors show very poor results. A well-defined treatment based on surgery and chemotherapy yields good results.

IntroductionTuberculosis is still endemic in Morocco and the urogenital form is common. This form is characterized by clinical polymorphism. However, the isolated ureteric form is very rare. The differential diagnosis might be raised in tumoral cases while undertaking surgical excision which is the realistic choice. Hence, we report an isolated ureteric tuberculosis case, and we discuss the clinical, imaging, diagnostic and therapeutical features.Case presentationA 30-year-old Moroccan man consulted us for left back pain associated with urinary frequency and a few macroscopic episodes of hematuria for the past six months. A computed tomography urography revealed a left hydronephrosis and hydroureter secondary to focal wall thickening of the left lumbar ureter. Hence, we had diagnosed a ureteral tumor. However, a clinical examination showed irritative voiding symptoms and epididymal disorders associated with prostate infection suggesting a Koch’s bacillus assessment of the patient’s urine of which the results proved strongly positive. The treatment consisted of establishing a double-J ureteric stent to drain the left kidney, followed by antituberculous antibiotics.ConclusionUrogenital tuberculosis is common in endemic countries, however isolated ureter affection is rare. It is important to consider a ureteral tuberculosis diagnosis whenever ureteral thickening is revealed in a patient living in a country in which tuberculosis is endemic.

No abstract

Objectifs: Evaluer les résultats de d'urétrorraphie termino-terminale dans le traitement des sténoses de l'urètre bulbaire et membraneux à travers l'étude de la série de notre service et une revue récente de la littérature. Patients et méthodes: Il s'agit d'une étude rétrospective basée sur la revue des dossiers médicaux des patients ayant bénéficiés d'une Urétrorraphie Termino-Terminale (UTT) dans notre formation entre Février 2006 et Février 2010. La moyenne d'âge des patients était de 38, 3 ans. L'étiologie du rétrécissement urétral était infectieuse et traumatique respectivement dans 40 % et 60% des cas. Chez 68 % d'entre eux, le rétrécissement urétral était localisé au niveau bulbaire et chez 32 % au niveau membraneux. Tous les patients avaient une sténose unique inférieure à 2 cm à l'urétro-cystographie rétrograde et mictionnelle.Résultats: La durée moyenne de suivi était de 28 mois. Le taux de succès de l'urétrorraphie termino-terminale dans notre étude était de 88 %. 12% des patients avaient présenté une récidive de la sténose. Tow patients (8%) ayant une sténose bulbaire avaient rapporté des troubles éjaculatoires. Aucun de nos patients (0%) n'avait présenté ni dysfonction érectile ni incontinence suite à cette intervention. Conclusion: L'urétroplastie anastomotique termino-terminale permet des taux élevés de reperméabilisation urétrale après une première procédure. Le taux de récidive de la sténose reste faible comparativement aux autres techniques chirurgicales. Les troubles éjaculatoires peuvent être prévenus par une dissection minutieuse et une restitution anatomique des muscles bulbo-caverneux.

Introduction: Prostate biopsy (PB) is a routine procedure performed by urologists in cases of suspected prostate cancer, any abnormality in the prostate-specific antigen (PSA) assay, and/or perceived by the digital rectal exam. Although this is a safe and rapid procedure, it is not without potentially serious complications, including infectious complications ranging from asymptomatic bacteriuria to acute prostatitis and even septic shock. Materials and methods: This work reports the experience of the urology department of the Hassan II University Hospital of Fez in the study of post-biopsy prostatitis through the analysis of a retrospective series of 538 cases during the period January 2014 - December 2018. Results: We report 11 cases of acute post-biopsy prostatitis diagnosed in the urology department of the Hassan II University Hospital in Fez. The bacteria most frequently involved in post-biopsy infections are gram-negative bacteria (Escherichia coli, Klebsiella pneumonia, Acinetobacter baumannii) although gram-positive cocci (Enterococcus faecalis and Staphylococcus saprophyticus) can also be responsible. Anaerobic bacteria are rarely found. The treatment of these post-biopsy infections is based on prolonged antibiotic therapy (3 to 6 weeks) using third-generation cephalosporins (Ceftriaxone). In our series, no death, septic shock, or prostatic abscess was found. The evolution was towards a good improvement under antibiotic treatment with discharge at home after 48 hours of apyrexia. Conclusion: The study of infectious complications secondary to prostate biopsy makes it possible to determine the most appropriate empirical (therapeutic and prophylactic) regimens to minimize the risks. Because of the prevalence of infection by multi-resistant bacteria, particularly to quinolones, the biopsy must be performed following the rules of antibiotic prophylaxis.